Comparative Pharmacology
Head-to-head clinical analysis: FAMOTIDINE CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE versus TRILYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FAMOTIDINE CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE versus TRILYTE.
FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE vs TRILYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Famotidine is a competitive histamine H2-receptor antagonist that inhibits gastric acid secretion by blocking H2 receptors on parietal cells. Calcium carbonate and magnesium hydroxide act as antacids, neutralizing gastric acid via chemical neutralization.
TRILYTE (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, ascorbic acid) is an osmotic laxative. The active components induce diarrhea by osmotically drawing water into the gastrointestinal lumen, thereby increasing stool volume and stimulating peristalsis. Sodium ascorbate and ascorbic acid enhance the osmotic effect.
1 tablet (famotidine 10 mg, calcium carbonate 800 mg, magnesium hydroxide 165 mg) orally once or twice daily as needed for heartburn; maximum 2 tablets in 24 hours.
Adults: 1 liter (L) orally every 10-15 minutes until 4 L total consumed; complete ingestion within 4 hours.
None Documented
None Documented
Famotidine: 2.5-3.5 hours (prolonged in renal impairment, up to 20 hours when CrCl <10 mL/min).
Not applicable; non-absorbed, acts locally in GI tract
Famotidine: renal (65-70% unchanged), biliary/fecal (30-35%). Calcium carbonate: feces (unabsorbed calcium), urine (absorbed). Magnesium hydroxide: feces (unabsorbed magnesium), urine (absorbed).
Renal excretion of intact electrolyte ions; negligible drug excretion
Category A/B
Category C
Antacid / Laxative
Laxative